2,4-DI(AMINOPHENYL)PYRIMIDINES AS PLK-KINASE INHIBITORS Russian patent published in 2010 - IPC C07D403/12 C07D403/14 C07D401/12 C07D401/14 C07D405/12 C07D413/12 C07D239/48 A61K31/506 A61K31/5513 A61K31/553 A61P29/00 A61P35/00 A61P37/00 

Abstract RU 2404979 C2

FIELD: medicine.

SUBSTANCE: invention refers to new compounds exhibiting antiproliferative activity of formula (1) where W means N or C-R2; X means -NH-; Y means CH; Z means halogen, -NO2, C2-C3alkynyl-, halogen-C1-C3alkyl- and -C(=O)-C1-C3alkyl, A means a group of formula (i), (ii) or (iii) Q1 means phenyl; B1, B2, B3 and B4 independently mean C-RgRh, N-Ri or O; R1 means hydrogen; R2 means a residue specified from the group including hydrogen, halogen and -OR4; Ra, Rb, Rc, Rd, Re and Rf independently mean hydrogen; Rg and Rh independently mean a residue specified from the group including hydrogen, =O, -OR4 and -NR4C(=O)R5; or mean optionally a residue monosubstituted or twice-substituted with equal or different substitutes and specified from the group including C1-C6alkyl and phenyl, the substitute/substitutes is/are specified from the group including R8/, -OR4, -C(=O)R4, -C(=O)OR4 and -C(=O)NR4R5 where R8/ and other values of radicals are specified in the patent claim, optionally in the form of their pharmacologically noncontaminating acid addition salts. The invention also concerns a pharmaceutical composition.

EFFECT: new compounds have effective biological properties.

8 cl, 6 dwg, 1086 ex

Similar patents RU2404979C2

Title Year Author Number
INHIBITIN CDK-KINASES PYRIMIDINES AND THEIR APPLICATION AS MEDICINES 2002
  • Brumbi Tomas
  • Jautelat Rol'F
  • Prin Olaf
  • Shefer Martina
  • Zimajster Gerkhard
  • Ljuking Ul'Trikh
  • Khuve Kristof
RU2330024C2
N-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITOR 2003
  • Uolles Ehli M.
  • Lissikehjtos Dzhozef P.
  • Kherli Brajan T.
  • Marlou Ehlison L.
RU2307831C9
THIAZOLYL DIHYDROQUINAZOLINES 2007
  • Brandl' Triksi
  • Majer Udo
  • Khenke Kristof
  • Jergensen Anne T.
  • Pauch Aleksander
  • Brajtfel'Der Shteffen
  • Grauert Mattias
  • Khoffmann Mattias
  • Shojerer Shtefan
  • Ehrb Klaus
  • Piper Mikhaehl'
  • Pragst Ingo
RU2430923C2
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION 1997
  • Lum Robert T.
  • Blum Cheri Linn
  • Makman Richard
  • Vik Majkl M.
  • Skou Stiven R.
RU2220968C2
THERAPEUTICALLY ACTIVE TRIAZOLES AND USE THEREOF 2007
  • Messinger Jozef
  • Shen Uve
  • Khuzen Bettina
  • Tole Genrikh-Khubert
  • Koskimies Pasi
  • Kallio Lila
RU2469042C2
PYRIMIDINE COMPOUND (VARIANTS) AND PHARMACEUTICAL COMPOSITION SHOWING AFFINITY TO DOPAMINE D-RECEPTORS 1995
  • Beate Khellendal'
  • Annegret Lanski
  • Rajner Munshauer
  • Zigfrid Bialojan
  • Liliane Unger
  • Khans-Jurgen Teshendorf
  • Karsten Vike
  • Karla Dresher
RU2172736C2
C-MET ANTAGONIST AND AMINOHETEROARYL COMBINATION FOR TREATING CANCER 2009
  • Getsh Lilian
RU2526171C2
SUBSTITUTED DERIVATIVES OF CYCLOHEXAN-1,4-DIAMINE, METHOD FOR THEIR PREPARING AND DRUG 2002
  • Zundermann Bernd
  • Khennis Khagen-Khajnrikh
  • Ehngl'Berger Verner
  • Kegel' Babetta-Ivonna
RU2321579C2
METHOD OF SYNTHESIS OF DERIVATIVES OF SUBSTITUTED 2-NITROGUANIDINE AND METHODS OF SYNTHESIS OF IN- TERMEDIATE COMPOUNDS 1998
  • Majenfish Peter
RU2202544C2
N3-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS 2003
  • Uolles Ehli M.
  • Lissikehjtos Dzhozef P.
  • Kherli Brajan T.
  • Marlou Ehlison L.
RU2300528C2

RU 2 404 979 C2

Authors

Shtadtmjuller Khajnts

Ehngel'Khardt Kharal'D

Shtegmajer Martin

Baum Anke

Gjurtler Ul'Rikh

Shop Andreas

Kvant Jens

Zol'Ka Flavio

Khauptmann Rudol'F

Rajzer Ul'Rikh

Tsan Shtefan Karl

Kherfurt Lars

Dates

2010-11-27Published

2005-08-18Filed